Greg Chrimes

Site Head & VP, Analytical and Formulation Sciences – Louisville, CO, United States 

Greg Chrimes has more than 25 years of hands-on experience leading therapeutic development and commercialization activities to serve patients in need. As the Vice President of Analytical and Formulation Sciences and Site Head for the Louisville facility, Greg leads high-performing teams as they employ the latest industry standards and cutting-edge technologies to bring advanced therapeutics to market. Since joining KBI in 2014, and previously Amgen and several other local biotechnology companies before that, Greg has supplied molecular biology purification kits, developed clinical diagnostics, and supported successful commercialization of multiple life-changing products. In addition to his abilities in mentorship and team development, his expertise includes method lifecycle management, product development and formulation, regulatory filing contributions, and product CQA establishment.  
 
Greg holds a bachelor’s degree in Cellular Biology and Biochemistry from the University of Northern Colorado.